Clinical trial
Study of Treatment Effects of Combination Therapy of Lucentis Plus Reduced…
NCT00455871 · Barnes Retina Institute, Other · Unknown status
Key facts
| NCT number | NCT00455871 |
|---|---|
| Title | Study of Treatment Effects of Combination Therapy of Lucentis Plus Reduced Fluence PDT With Visudyne in Patients With Exudative AMD |
| Official title | An Open-Label, Single-Site, Comparative, Pilot Study of the Treatment Effects of Combination Therapy of Lucentis (Ranibizumab) Plus Reduced Fluence Photodynamic Therapy With Visudyne in Patients With Exudative Age-Related Macular Degeneration (AMD) |
| Lead sponsor | Barnes Retina Institute, Other |
| Collaborators | QLT Inc. Industry |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Age-Related Macular Degeneration |
| Intervention type | Drug |
| Interventions | reduced fluence photodynamic therapy with Visudyne, Lucentis |
| Enrollment | 30 |
| Start date | Apr 1, 2007 |
| Primary completion | Oct 1, 2010 |
| Completion | Oct 1, 2010 |
| First posted | Apr 4, 2007 |
| Last update posted | May 9, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: